KT Activities

KT Team Publications

  • Rothfus M, Sketris IS, Traynor R, Helwig M, Stewart SA. (2016). Measuring knowledge translation uptake using citation metrics: a case study of a pan-Canadian network of pharmacoepidemiology researchers. Science & Technology Libraries. View >>>

 

Click here to view all of the CNODES publications.

Research Abstracts and Poster Presentations

CNODES members have delivered over 120 presentations, disseminating our study results, methods, knowledge translation initiatives, and overall CNODES mandate to national and international audiences. Please see a sample of the presentations below:

  • Carter J, Sketris I, Tamim H, Levy A, Langley J (2015). Determining proton pump inhibitor prescription dispensing patterns for Nova Scotia seniors pharmacare program beneficiaries. J Popul Ther Clin Pharmacol, 22(3):e251-e284. [Abstract #42 *Encore presentation; initially presented at 31st Annual International Society for Pharmacoepidemiology Meeting.]
  • Chateau D (2014, April). Addressing confounding through creative cohort construction: CNODES analysis of PPIs and pneumonia. Presentation at the 2014 International Health Data Linkage Conference, Vancouver, BC, CAN
  • Dormuth C (2014, October). Multicentre database study of statins and diabetes: A Health Canada query and CNODES response. Seminar at the DSECT/DSEN webinar series: Drug safety and effectiveness cross-disciplinary training, Ottawa, ON, CAN.
  • Dormuth C, Brookhard MA, Morrow RL, Miller TA, Platt R (2013, August). Serious adverse events associated with use of stimulants: An instrumental variable approach. Presentation at the 29th International Conference on Pharamacoepidemiology & Therapeutic Risk Management, Montreal, QC, CAN.
  • Ernst P (2014, May). SNRI & AKI: A CNODES study. Workshop at McGill University’s Department of Medicine Research Symposium, Montreal, QC, CAN.
  • Filion K (2016, September). Incretin-based drugs and the risk of heart failure: A multi-database study by the Canadian Network for Observational Drug Effect Studies. Presentation at the Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA.
  • Filion K, Cocoros N, Hennesy S, Fuller C, Kawai A, Toh D (2016, June). Public health surveillance using distributed data networks: Lessons from FDA’s Sentinel Initiative and the CNODES. Presentation at the Epidemiology Congress of the Americas 2016, Miami, FL, USA.
  • Henry D (2015, August). The value of a distributed network of data centers in quantifying uncommon adverse effects of drugs. Presentation at the Farr Institute International Conference 2015: Data intensive health research and care, St. Andrews, SCT.
  • Henry D, Sketris I (2013, November). Real applications and lessons learned in knowledge translation. Panel discussion at the 2013 Canadian Association of Population Therapeutics annual conference, Toronto, ON, CAN.
  • Lelorier J, MacDonald T, Begaud B (2013, August). Keynote session: The neglected half of pharmacoepidemiology. Panel discussion at the 29th International Conference on Pharamacoepidemiology & Therapeutic Risk Management, Montreal, QC, CAN.
  • Pang M (2014, August). Performance of targeted maximum likelihood estimation in point-exposure studies using high-dimensional covariate data. Presentation at the 35th Annual Conference of the International Society for Clinical Biostatistics, Vienna, AUT.
  • Platt R (2014, September). Discussion: Is observational research useful for safety surveillance? Symposium at the 1st Seattle Symposium on Healthcare Data Analytics, Seattle, WA, USA.
  • Platt R, Chateau D (2016, May). Observational studies of drug safety in distributed data networks: How the Canadian Network for Observational Drug Effect Studies does it. Webinar for the Canadian Society for Epidemiology and Biostatistics, CAN.
  • Platt R, Dormuth C, Henry D. (2014, December). Higher potency statins and the risk of new diabetes: multicenter, observational study of administrative databases. Workshop at the Patient-Centered Outcomes Research Institute: Distributed analysis in healthcare data, Washington, DC, USA.
  • Platt R, Henry D, Ernst P, Lix L, Chateau D, Dormuth C (2014, April). Observational studies of drug safety in distributed data networks: Experience from the Canadian Network for Observational Drug Effect Studies. Sub-plenary at the 2014 International Health Data Linkage Conference, Vancouver, BC, CAN.
  • Rothfus M, Sketris I, Helwig M, Traynor R, Stewart S (2015, October). Determining the citation impact of CNODES publications: Methods and outcomes. Seminar at the IMPART Research Seminar Series at Dalhousie University’s College of Pharmacy, Halifax, NS, CAN.
  • Suissa S, Ernst P (2014, November). Are medications safe? The good, the bad, the ugly. Lecture at McGill University’s Mini-Med, Montreal, QC, CAN.

CNODES Project Abstracts Prepared for DSEN

Media Releases

  • Jewish General Hospital, Lady Davis Institute research news, “New study finds anti-diabetic incretin-based drugs are not associated with an increased risk of heart failure” View > > >